×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Kimberly Manhard

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
INBXInhibrx Biosciences, Inc.Kimberly ManhardDirectorAug 28, 2024Buy$13.9810,000139,80010,000Aug 30, 2024, 04:16 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 13, 2023Tax Payment (Shares)$2.881,4174,08128,330Apr 17, 2023, 05:26 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 13, 2023Option/RSU Exercise-5,814-29,747Apr 17, 2023, 05:26 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentOct 31, 2022Other Acquisition or Disposition$3.271,6555,41620,131Jan 17, 2023, 05:34 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJan 13, 2023Tax Payment (Shares)$3.172,0126,37823,933Jan 17, 2023, 05:34 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJan 13, 2023Option/RSU Exercise-5,814-25,945Jan 17, 2023, 05:34 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentOct 13, 2022Tax Payment (Shares)$3.762,0127,56518,476Oct 17, 2022, 04:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentOct 13, 2022Option/RSU Exercise-5,814-20,488Oct 17, 2022, 04:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJul 13, 2022Tax Payment (Shares)$3.012,0126,05614,674Jul 15, 2022, 04:55 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJul 13, 2022Option/RSU Exercise-5,814-16,686Jul 15, 2022, 04:55 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 29, 2022Other Acquisition or Disposition$3.841,5045,77812,376May 04, 2022, 07:01 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentMay 03, 2022Sale$4.761,5047,15410,872May 04, 2022, 07:01 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 13, 2022Tax Payment (Shares)$6.072,01212,21310,872Apr 15, 2022, 05:03 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 13, 2022Option/RSU Exercise-5,814-12,884Apr 15, 2022, 05:03 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJan 13, 2022Tax Payment (Shares)$8.302,01216,7007,070Jan 14, 2022, 05:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJan 13, 2022Option/RSU Exercise-5,814-9,082Jan 14, 2022, 05:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentOct 13, 2021Tax Payment (Shares)$10.554334,5683,268Oct 15, 2021, 04:22 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentOct 13, 2021Option/RSU Exercise-1,250-3,701Oct 15, 2021, 04:22 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJul 13, 2021Option/RSU Exercise-1,250-2,884Jul 15, 2021, 04:47 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJul 13, 2021Tax Payment (Shares)$13.484335,8372,451Jul 15, 2021, 04:47 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 13, 2021Tax Payment (Shares)$16.664337,2141,634Apr 15, 2021, 04:51 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentApr 13, 2021Option/RSU Exercise-1,250-2,067Apr 15, 2021, 04:51 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJan 13, 2021Tax Payment (Shares)$18.164337,863817Jan 15, 2021, 04:25 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentJan 13, 2021Option/RSU Exercise-1,250-1,250Jan 15, 2021, 04:25 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentDec 22, 2020Option/RSU Exercise$13.0010,000130,00010,000Dec 23, 2020, 04:23 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardEVP, Drug DevelopmentDec 22, 2020Sale$20.0010,000200,0000Dec 23, 2020, 04:23 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentApr 30, 2020Other Acquisition or Disposition$12.121,15814,0361,158May 01, 2020, 06:48 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentMay 01, 2020Sale$13.971,15816,1760May 01, 2020, 06:48 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentNov 29, 2019Option/RSU Exercise$13.0024,000312,00024,000Dec 03, 2019, 06:30 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentNov 29, 2019Sale$26.0024,000624,0000Dec 03, 2019, 06:30 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentApr 30, 2019Other Acquisition or Disposition$18.431,10920,4371,109May 02, 2019, 08:40 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentMay 01, 2019Sale$18.861,10920,9180May 02, 2019, 08:40 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentOct 31, 2018Other Acquisition or Disposition$23.6049411,656494Nov 02, 2018, 09:17 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentNov 02, 2018Sale$30.6249415,1250Nov 02, 2018, 09:17 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentOct 01, 2018Sale$32.076,000192,4330Oct 02, 2018, 09:12 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentOct 01, 2018Option/RSU Exercise$13.006,00078,0006,000Oct 02, 2018, 09:12 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentJul 02, 2018Option/RSU Exercise$13.006,00078,0006,000Jul 03, 2018, 09:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentJul 02, 2018Sale$37.536,000225,179100Jul 03, 2018, 09:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentMar 19, 2018Option/RSU Exercise$13.0018,000234,00018,000Mar 19, 2018, 07:24 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentMar 19, 2018Sale$30.0018,000540,0000Mar 19, 2018, 07:24 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentJan 10, 2018Option/RSU Exercise$13.007,58498,5927,584Jan 12, 2018, 04:21 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentJan 10, 2018Sale$20.007,584151,6800Jan 12, 2018, 04:21 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentApr 24, 2017Option/RSU Exercise$8.9921,542193,64321,542Apr 24, 2017, 08:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardExecutive VP, Drug DevelopmentApr 24, 2017Sale$15.3321,542330,2630Apr 24, 2017, 08:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardDirectorJun 02, 2015Option/RSU Exercise$8.8010,50092,40010,500Jun 03, 2015, 06:46 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardDirectorJun 02, 2015Sale$23.5810,500247,5900Jun 03, 2015, 06:46 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardDirectorJun 01, 2015Option/RSU Exercise$9.052,70824,5072,708Jun 03, 2015, 06:46 PM
HRTXHERON THERAPEUTICS, INC. /DE/Kimberly ManhardDirectorJun 01, 2015Sale$21.172,70857,3280Jun 03, 2015, 06:46 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe